Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
11.16
-0.95 (-7.84%)
At close: Nov 10, 2026, 4:00 PM EST
11.20
+0.04 (0.36%)
After-hours: Nov 10, 2026, 6:45 PM EST
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.57 billion as of November 10, 2026. It is the 7,324th most valuable company in the world and the 1,882nd biggest in the United States. Its market cap has increased by 7.53% in one year.
Market Cap
1.57B
Enterprise Value
1.18B
1-Year Change
7.53%
Global Rank
Country Rank
#1,882 United States
Category
ChartMarket Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.57B, an increase of 106.79%. That is a compound annual growth rate of 7.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.59B | 52.99% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 1.70B |
| Kailera Therapeutics | 1.68B |
| Generate Biomedicines | 1.68B |
| Nurix Therapeutics | 1.67B |
| Precigen | 1.60B |
| Immunocore Holdings | 1.60B |
| Ultragenyx Pharmaceutical | 1.57B |
| Nanobiotix | 1.53B |